After careful consideration, the Board of Trustees of Pacer Funds Trust has determined to close and liquidate the Pacer CFRA-Stovall Equal Weight Seasonal Rotation ETF (NYSE: SZNE) (the "Fund"). Pacer ...
Hosted on MSN
CFRA sees more market upside despite seasonal risks
CFRA chief strategist Sam Stovall expects the S&P 500 to post further gains this year, supported by stronger-than-expected earnings and a resilient economic backdrop. While acknowledging the ...
Learn everything you need to know about Pacer CFRA-Stovall Eq WghtSeasnlRottnETF (SZNE) and how it ranks compared to other funds. Research performance, expense ratio, holdings, and volatility to see ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Wall Street’s sentiment appears to be shifting as CFRA Research upgrades its outlook for the S&P 500, pointing to a continued rally through the remainder of 2025 and into 2026. The firm, led by Chief ...
Almost all California employers will soon be impacted by an impending expansion to the California Family Rights Act (CFRA) under SB-1383, which was signed into law by Governor Gavin Newsom on ...
NEW YORK--(BUSINESS WIRE)--CFRA, one of the world’s largest providers of independent investment research, today announced that it will offer individual retail investors complimentary 90-day access to ...
CFRA's Sam Stovall anticipates the stock market can go higher even without rate cuts, but has the playbook to navigate a possible correction if one develops. The chief investment strategist expects ...
NEW YORK--(BUSINESS WIRE)--CFRA, one of the world’s largest providers of independent investment research, today announced a number of significant enhancements and updates to its industry-leading ETF ...
On March 4, 2015, the California Fair Employment and Housing Council approved updates to the California Family Rights Act (CFRA) regulations. These updates, which took effect on July 1, 2015, clarify ...
In spite of Covid-19 and global recession concerns, we have a positive outlook on the biotechnology sub-industry; we expect to see a ramp-up in new drug sales; the continued development of many new, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results